More than any other group, Latinos in Minnesota remained in the workforce during the COVID-19 pandemic. But many found themselves on divergent paths.
Earlier this year, the FDA approved Spravato, a move that gave the controversial practice of using ketamine to treat depression an air of professional legitimacy. But insurance companies have been slow to sanction the treatment.
The rally, which was organized by three Somali-American women, drew well over 100 supporters, including a bevy of elected DFL officeholders, representatives from local labor unions and even Amazon tech workers from Seattle.
Miguel Fraga, the first secretary of the Cuban Embassy in Washington, D.C., is in Minnesota giving a series of talks on developing relations between Cuba and the U.S.
As demographic changes transform the student makeup of many classrooms around the state, they have also impacted the state’s high school sports scene.
The bonding bill approved by the Minnesota Legislature this year includes a lot of projects to be paid off not from the general fund, but from dipping into other sources of money, some of which were established with specialized purposes.
“It’s a huge deal and it’s causing a lot of stir in the medical education world,” Patty Hobday, an assistant professor of pediatrics at the University of Minnesota Medical School, says of EPAC.
The latest fundraiser for the Women of Nations shelter wasn’t your run-of-the-mill charity ball, unless your normal event features body slams, a ladder match and a 20-person battle royal.
The Minnesota Ketamine Clinic is among a small number of places in the U.S. offering the treatment — a practice that is divisive within the psychiatric community.
Encountering a foreign-born doctor in Greater Minnesota once might have been unusual. If the state’s health-care trends continue as they have, it won’t be much longer.
